MedPath

Biomarker study of folate receptor alpha(FOLRa)using paired samples of breast cancer tissue

Not Applicable
Recruiting
Conditions
Breast cancer
Registration Number
JPRN-UMIN000050787
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1.Not undergoing systemic therapy 2.Patients deemed unsuitable by a physician for other reasons

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of the patients with FOLRa-positive breast cancer
Secondary Outcome Measures
NameTimeMethod
Proportions of cases with increased, unchanged, or decreased IHC scores for FOLRa in paired samples (primary vs. metastatic, pre- vs. post-treatment) Correlation of FOLRa scores in cell membrane, cytoplasm, and cell membrane + cytoplasm Association between FOLRa expression and ER/PgR positivity, Ki-67 index, and PD-L1 positivity Relationship between treatment regimen and changes in FOLRa expression levels
© Copyright 2025. All Rights Reserved by MedPath